Corcept Therapeutics | CORT - Marktkapitalisierung

Aktienkurs
46.06
Täglich Wechseln
0.98 2.17%
Monatlich
13.81%
Jährlich
-35.77%
Q2 Prognose
45.07




Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Alaunos Therapeutics USD 5M 5M 2025-09
ANI Pharmaceuticals USD 1.77B 269M 2025-12
Ardelyx USD 1.42B 89M 2025-12
Aurora Cannabis CAD 327.21M 142.93M 2025-12
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Canopy Growth CAD 656.46M 124.89M 2025-12
Corcept Therapeutics USD 3.66B 5.1B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Esperion Therapeutics USD 885M 351M 2025-12
J&J USD 561.65B 17.5B 2026-04
Knight Therapeutics CAD 600.53M 14.56M 2025-12
Lexicon Pharmaceuticals USD 418M 73M 2025-12
Merck USD 261.26B 51.62B 2025-12
Nektar Therapeutics USD 14.34B 13.48B 2026-04
Novartis USD 292.21B 26.55B 2025-12
Novartis USD 263.08B 17.01B 2025-12
Pacira USD 1.06B 94M 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Supernus Pharmaceuticals USD 2.85B 151M 2025-12
TG Therapeutics USD 4.73B 1B 2025-12